Paper number: CC02 MACRO %NEWFLOW JIAN HUA (DANIEL) HUANG, FOREST LABORATORIES INC, NJ
|
|
- Lawrence Cox
- 5 years ago
- Views:
Transcription
1 Paper number: CC02 MACRO %NEWFLOW JIAN HUA (DANIEL) HUANG, FOREST LABORATORIES INC, NJ ABSTRACT: If you use SAS Proc Report frequently, you will be familiar with the flow option. The flow option wraps the value of a character variable in its column, and it honors the split character which is defined in Proc Report. However, the flow option has two limitations. First, it dose not allow you to insert any indent spaces before wrapped lines. Second, if a character variable contains leading blank space, the flow option dose not carry on the leading blank space to wrapped lines. A macro program called %NEWFLOW has been designed to overcome these limitations. In this paper, I will demonstrate the application of %NEWFLOW with examples, discuss the logics of %NEWFLOW with a flowchart, and finally, give the source code of the macro program. BACKGROUND: There are multiple ways to generate a report. Among them, I used proc report procedure a lot. Because I find it is straight forward, dynamic and with many options available. One option called flow is very useful, it wraps the text string in its column and it honors the split character. However, in some cases, flow option dose not work well. For example, if I want to insert certain indent space in the beginning of wrapped lines, or if the original text string contains some leading blank spaces, and I want to carry on the same leading blank spaces to wrapped lines, the flow option itself does not work well. Therefore, I designed a macro program called %NEWFLOW. With the help of %NEWFLOW, the flow option can achieve the new functions by inserting indent spaces or carrying on leading blank spaces into wrapped lines. In next three chapters, I will discuss about the applications, logics and SAS codes of the macro. 1
2 APPLICATION OF %NEWFLOW: The application of %NEWFLOW is demonstrated by examples of AE tables summarized by Body System and Preferred term. The outputs of AE tables, before and after using %NEWFLOW, are listed and compared. Table 1 is a regular AE table output before applying %NEWFLOW. The ID column (the first column in the table) contains the character values of AE terms. Because multiple treatments (treat 1 - treat n) are required in this table, the ID column dose not has enough space to list every AE on one line. Therefore, flow option is called, and some AE with long text strings are wrapped. However, in this typical AE table summarized by two levels of AE terms, the lower level of AE terms (Preferred Terms) contain two leading blank space, when they are wrapped by flow option only, those leading blank spaces can not be carried on to wrapped lines. Table 1. AE tables summarized by SOC and Preferred Terms (Not apply %NEWFLOW macro and ID column without enough spaces) Body System Term Preferred Term Placebo Treat 1 Treat 2... Treat n Patient with at least one TEAE xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) Blood and lymphatic system xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) disorders Anaemia xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) Haemorrhagic anaemia xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) Leukocytosis xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) Neutropenia xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) Cardiac disorders xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) Aortic valve incompetence xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) Atrial tachycardia xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) Atrioventricular block xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) first degree Bundle branch block right xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) Cardiac valve sclerosis xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) Cardiomyopathy xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) Endocarditis noninfective xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) Mitral valve disease xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) Mitral valve incompetence xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) Mitral valve prolapse xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) Palpitations xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) Postural orthostatic xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) tachycardia syndrome Sinus bradycardia xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) 2
3 In order to solve this problem, before using flow option, I apply %NEWFLOW macro on AE result dataset. Calling %NEWFLOW is just as simple as one line SAS statement as below: data result; set result; %Newflow(varin=aeterms, flowlen=30, indent=0, split=%str( )); run; (*Table definition of macro parameters is given later after the source SAS code) Table 2 is the AE table output after applying %NEWFLOW. The leading blank spaces for AE preferred terms are kept in wrapped lines. The output table looks more formal and neat than Table 1. Table 2. AE tables summarized by SOC and Preferred Terms (Apply %NEWFLOW macro: indent space=0) Body System Term Preferred Term Placebo Treat 1 Treat 2... Treat n Patient with at least one TEAE xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) Blood and lymphatic system xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) disorders Anaemia xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) Haemorrhagic anaemia xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) Leukocytosis xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) Neutropenia xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) Cardiac disorders xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) Aortic valve incompetence xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) Atrial tachycardia xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) Atrioventricular block first xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) degree Bundle branch block right xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) Cardiac valve sclerosis xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) Cardiomyopathy xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) Endocarditis noninfective xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) Mitral valve disease xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) Mitral valve incompetence xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) Mitral valve prolapse xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) Palpitations xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) Postural orthostatic xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) tachycardia syndrome Sinus bradycardia xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) 3
4 In addition to keeping the leading blank spaces, %NEWFLOW allows you to add extra indent spaces into wrapped lines. This function is done by defining macro option indent= with number of indent space. data result; set result; %Newflow(varin=aeterms, flowlen=30, indent=1, split=%str( )); run; Table 3 shows the AE output with wrapped lines carrying leading blank space plus one indent space. Please note that one indent space is also applied on the wrapped line for AE Body System term, ie. Blood and lymphatic system disorders. Table 3. AE tables summarized by SOC and Preferred Terms (Apply %NEWFLOW macro: indent space=1) Body System Term Preferred Term Placebo Treatment 1 Treatment 2 Treatment Patient with at least one TEAE xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) Blood and lymphatic system xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) disorders Anaemia xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) Haemorrhagic anaemia xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) Leukocytosis xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) Neutropenia xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) Cardiac disorders xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) Aortic valve incompetence xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) Atrial tachycardia xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) Atrioventricular block first xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) degree Bundle branch block right xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) Cardiac valve sclerosis xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) Cardiomyopathy xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) Endocarditis noninfective xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) Mitral valve disease xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) Mitral valve incompetence xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) Mitral valve prolapse xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) Palpitations xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) Postural orthostatic xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) tachycardia syndrome 4
5 LOGIC OF %NEWFLOW: The following chart presents the logic of %NEWFLOW macro in 3 steps: Varin= Neoplasms benign, malignant and unspecified (incl cysts and polyps) Step 1, cut input variable into two parts at the last blank space within flow length. Neoplasms benign, malignant and unspecified (incl cysts and polyps) Neoplasms benign, malignant and unspecified (incl cysts and polyps) Step 3, combine every part together as the value of output variable Step 2, add split character on first part, and add leading & indent spaces on remaining part. and unspecified (incl cysts + Repeat step 1&2 on + + and polyps) Varout= Neoplasms benign, malignant and unspecified (incl cysts and polyps) 5
6 SOURCE CODE OF %NEWFLOW: Finally, the SAS source code and variable definition tables are given as below: %Macro newflow (varin=, varout=, flowlen=, indent=0, split=%str( )); %let a_len=%eval(&flowlen+4); length &varout remain temp $500 part $&flowlen apart $&a_len; *-set output variable (varout=) as the same as input variable (varin=) if varout is not specified; %if &varout eq %then %do; %let varout=&varin; % ledspace=length(&varin)-length(left(&varin)) + %eval(&indent); temp=trim(&varin); if length( temp)> &flowlen then do; &varout= " "; exit=100; do i = 1 to exit; if substr( temp,&flowlen,1)=" " or substr( temp,%eval(&flowlen + 1),1)=" " then do; part=substr( temp,1,&flowlen); if length( temp)> &flowlen then do; apart=part "&split"; else do; apart=" " part; if &varout ^= " " then &varout=trim(&varout) trim(apart); else &varout=trim(apart); remain=substr( temp,%eval(&flowlen + 1)); if ledspace =0 then remain=strip(remain); else if ledspace =1 then remain='' strip(remain); else remain=repeat(' ', ledspace-1) strip(remain); else do; endpos=&flowlen - indexc(reverse(substr( temp,1,&flowlen)),''); part=substr( temp,1, endpos); if length( temp)> &flowlen then do; apart=part "&split"; else do; apart=" " part; if &varout ^= " " then &varout=trim(&varout) trim(apart); else &varout=trim(apart); remain=substr( temp, endpos+1); if ledspace =0 then remain=strip(remain); else if ledspace=1 then remain='' strip(remain); else remain=repeat(' ', ledspace-1) strip(remain); temp=remain; if temp=" " then i=exit; %mend newflow; 6
7 Definition table of macro parameters: Parameter definition default value varin list input variable name varin= varout list output variable name (if it is blank, then use the input variable name as varout= the output variable name) flowlen define the length of flow length (shall be less than column length ) flowlen= indent indicate how many indent spaces are given to wrapped lines ( in addition to indent=0 leading blank spaces) split specify the split character (the same split character defined in proc report ) split=%str( ) CONCLUSION: In conclusion, the %NEWFLOW macro allows people to keep the leading blank spaces or add extra indent spaces into wrapped lines. It increases the flexibility of using SAS flow option. The macro itself is simple, straight forward and easy to use. CONTACT INFORMATION: Your comments and questions are valued and encouraged. Please contact the author at: Daniel Huang, MSc, MPH, Forest Research Institute Harborside Financial Center, Plaza V, Jersey City, NJ Tel: Jian.huang@frx.com SAS and all other SAS Institute Inc. product or service names are registered trademarks or trademarks of SAS Institute Inc. in the USA and other countries. indicates USA registration. Other brand and product names are registered trademarks or trademarks of their respective companies 7
Kick It Old School - Creating Reports with the DATA _NULL_ Step
Kick It Old School - Creating Reports with the DATA _NULL_ Step Sai Ma, PharmaNet/i3, Toronto, Ontario Canada Suwen Li, Everest Clinical Research Services Inc., Markham, Ontario Canada Minlan Li, Everest
More informationA SAS Macro to Present a Summary Table of the Number of Patients Having Experienced Adverse Events in a Clinical Trial
A SAS Macro to Present a Summary Table of the Number of Patients Having Experienced Adverse Events in a Clinical Trial Christoph Gerlinger * and Ursula Franke ** * Laboratoires Fournier S.C.A. and ** biodat
More informationPROGRAMMER S SAFETY KIT: Important Points to Remember While Programming or Validating Safety Tables
PharmaSUG 2012 - Paper IB09 PROGRAMMER S SAFETY KIT: Important Points to Remember While Programming or Validating Safety Tables Sneha Sarmukadam, Statistical Programmer, PharmaNet/i3, Pune, India Sandeep
More informationCommon Codes for ICD-10
Common Codes for ICD-10 Specialty: Cardiology *Always utilize more specific codes first. ABNORMALITIES OF HEART RHYTHM ICD-9-CM Codes: 427.81, 427.89, 785.0, 785.1, 785.3 R00.0 Tachycardia, unspecified
More informationA DAYS CARDIOVASCULAR UNIT GUIDE DUE WEDNESDAY 4/12
A DAYS CARDIOVASCULAR UNIT GUIDE DUE WEDNESDAY 4/12 MONDAY TUESDAY WEDNESDAY THURSDAY FRIDAY 3/20 - B 3/21 - A 3/22 - B 3/23 - A 3/24 - B 3/27 - A Dissection Ethics Debate 3/28 - B 3/29 - A Intro to Cardiovascular
More informationPresented by Sata Hackenbruck 6 August 2009 State of Oregon SAS Users Group Meeting
Presented by Sata Hackenbruck 6 August 2009 State of Oregon SAS Users Group Meeting Explore following SAS text functions: COMPRESS TRANWRD SCAN Here is the problem I am analyzing pharmacy data and I want
More informationExtract Information from Large Database Using SAS Array, PROC FREQ, and SAS Macro
SESUG 2016 Paper CC-160 Extract Information from Large Database Using SAS Array, PROC FREQ, and SAS Macro Lifang Zhang, Department of Biostatistics and Epidemiology, Augusta University ABSTRACT SAS software
More informationAmbulatory Blood Pressure Monitoring
Ambulatory Blood Pressure Monitoring and Devices Chapter.1 Enrollment..................................................................... -2.2 Benefits, Limitations, and Authorization Requirements...........................
More informationA SAS sy Study of ediary Data
A SAS sy Study of ediary Data ABSTRACT PharmaSUG 2017 - Paper BB14 A SAS sy Study of ediary Data Amie Bissonett, inventiv Health Clinical, Minneapolis, MN Many sponsors are using electronic diaries (ediaries)
More informationAMBULATORY BLOOD PRESSURE MONITORING AND DEVICES CSHCN SERVICES PROGRAM PROVIDER MANUAL
AMBULATORY BLOOD PRESSURE MONITORING AND DEVICES CSHCN SERVICES PROGRAM PROVIDER MANUAL FEBRUARY 2018 CSHCN PROVIDER PROCEDURES MANUAL FEBRUARY 2018 AMBULATORY B LOOD PRESSURE MONITORING AND DEVICES Table
More informationSystematic Inductive Method for Imputing Partial Missing Dates in Clinical Trials
Paper PO05 Systematic Inductive Method for Imputing Partial Missing Dates in Clinical Trials Ping Liu ABSTRACT In any phase of clinical trials, dates are very critical throughout the entire trial. However,
More informationCardiology/Cardiothoracic
Cardiology/Cardiothoracic ICD-9-CM to ICD-10-CM Code Mapper 800-334-5724 www.contexomedia.com 2013 ICD-9-CM 272.0 Pure hypercholesterolemia 272.2 Mixed hyperlipidemia 272.4 Other and hyperlipidemia 278.00
More informationChapter. CPT only copyright 2010 American Medical Association. All rights reserved. 11Blood Pressure Devices and Supplies
11Blood Pressure Devices and Supplies Chapter 11 11.1 Enrollment..................................................................... 11-2 11.2 Benefits, Limitations, and Authorization Requirements...........................
More informationMatters of the Heart: Comprehensive Cardiology SARAH BEANLANDS RN BSCN MSC
Matters of the Heart: Comprehensive Cardiology SARAH BEANLANDS RN BSCN MSC Who am I? Class Outline Gross anatomy of the heart Trip around the heart Micro anatomy: cellular and tissue level Introduction
More informationThe Heart and Heart Disease
The Heart and Heart Disease Illustration of the heart by Leonardo DaVinci heart-surgeon.com/ history.html 2/14/2010 1 I. Location, Size and Position of the Heart A. Triangular organ located 1. of mass
More informationCorlanor. Corlanor (ivabradine) Description
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.40.05 Subject: Corlanor Page: 1 of 5 Last Review Date: June 24, 2016 Corlanor Description Corlanor (ivabradine)
More informationAppropriate Use Criteria for Initial Transthoracic Echocardiography in Outpatient Pediatric Cardiology (scores listed by Appropriate Use rating)
Appropriate Use Criteria for Initial Transthoracic Echocardiography in Outpatient Pediatric Cardiology (scores listed by Appropriate Use rating) Table 1: Appropriate indications (median score 7-9) Indication
More informationChapter 3 Software Packages to Install How to Set Up Python Eclipse How to Set Up Eclipse... 42
Table of Contents Preface..... 21 About the Authors... 23 Acknowledgments... 24 How This Book is Organized... 24 Who Should Buy This Book?... 24 Where to Find Answers to Review Questions and Exercises...
More informationPhUSE. PhUSE Computational Science Standard Analyses and Code Sharing Working Group
PhUSE PhUSE Computational Science Standard Analyses and Working Group Script Discovery and Acquisition Project Team Screen Shots of the Displays Created Using Scripts 1 Table of Contents 1. Disclaimer...
More informationKERN COMMUNITY COLLEGE DISTRICT CERRO COSO COLLEGE HCRS C255 COURSE OUTLINE OF RECORD
KERN COMMUNITY COLLEGE DISTRICT CERRO COSO COLLEGE HCRS C255 COURSE OUTLINE OF RECORD 1. DISCIPLINE AND COURSE NUMBER: HCRS C255 2. COURSE TITLE: Basic Cardiac Rhythm Interpretation 3. SHORT BANWEB TITLE:
More informationProgrammatic Challenges of Dose Tapering Using SAS
ABSTRACT: Paper 2036-2014 Programmatic Challenges of Dose Tapering Using SAS Iuliana Barbalau, Santen Inc., Emeryville, CA Chen Shi, Santen Inc., Emeryville, CA Yang Yang, Santen Inc., Emeryville, CA In
More informationPharmaceutical Applications
Creating an Input Dataset to Produce Incidence and Exposure Adjusted Special Interest AE's Pushpa Saranadasa, Merck & Co., Inc. Abstract Most adverse event (AE) summary tables display the number of patients
More informationGuideline-Directed Medical Therapy
Guideline-Directed Medical Therapy Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients with Functional Mitral Regurgitation OPTIMAL THERAPY (As defined in
More informationCreating Multiple Cohorts Using the SAS DATA Step Jonathan Steinberg, Educational Testing Service, Princeton, NJ
Creating Multiple Cohorts Using the SAS DATA Step Jonathan Steinberg, Educational Testing Service, Princeton, NJ ABSTRACT The challenge of creating multiple cohorts of people within a data set, based on
More informationImplementing Worst Rank Imputation Using SAS
Paper SP12 Implementing Worst Rank Imputation Using SAS Qian Wang, Merck Sharp & Dohme (Europe), Inc., Brussels, Belgium Eric Qi, Merck & Company, Inc., Upper Gwynedd, PA ABSTRACT Classic designs of randomized
More informationClinialTrials.gov Identifier: sanofi-aventis. Sponsor/company: 07/November/2008
These results are supplied for informational purposes only. Prescribing decisions should be made based on the approved package insert in the country of prescription Sponsor/company: sanofi-aventis ClinialTrials.gov
More informationData Analysis and Query Building with MedDRA
Data Analysis and Query Building with MedDRA MedDRA was developed under the auspices of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH). The
More information1. The most common extra-intestinal manifestation of inflammatory bowel disease is:
ALU 301 Sample Questions 1. The most common extra-intestinal manifestation of inflammatory bowel disease is: 1. uveitis 2. fatty liver 3. arthritis 4. pyoderma gangrenosum 2. Cardiomyopathy characterized
More informationSkin supplied by T1-4 (medial upper arm and neck) T5-9- epigastrium Visceral afferents from skin and heart are the same dorsal root ganglio
Cardio 2 ECG... 3 Cardiac Remodelling... 11 Valvular Diseases... 13 Hypertension... 18 Aortic Coarctation... 24 Erythropoiesis... 27 Haemostasis... 30 Anaemia... 36 Atherosclerosis... 44 Angina... 48 Myocardial
More informationSupplementary Online Content
Supplementary Online Content Chawla SP, Papai Z, Mukhametshina G, et al. First-line aldoxorubicin vs doxorubicin in metastatic or locally advanced unresectable soft-tissue sarcoma: a phase 2b randomized
More informationComplex Left Atrial (CLA) Best Practices for Navigant
Complex Left Atrial (CLA) Best Practices for Navigant Ischemic Ventricular Tachycardia (VT) Best Practices for Navigant Ischemic VT Ablation Procedures Set Up In the absence of a septal defect or other
More informationUnit 6: Circulatory System. 6.2 Heart
Unit 6: Circulatory System 6.2 Heart Functions of Circulatory System 1. The heart is the pump necessary to circulate blood to all parts of the body 2. Arteries, veins and capillaries are the structures
More informationECG Analysis and Interpretation Course Table of Contents:
ECG Analysis and Interpretation Course Table of Contents: Course Outline Overview/Rationale Aims of the Unit Objectives Content Teaching and Learning Methods Assessment Procedures Resources/Mode of Delivery
More informationOCCDS Creating flags or records. Rob Wartenhorst PhUSE Barcelona 2016
OCCDS Creating flags or records Rob Wartenhorst PhUSE Barcelona 2016 Introduction ADAE, ADCM and ADMH originally set up using ADAE structure. After release of OCCDS guide attempted to implement the occurrence
More informationReview Questions in Introductory Knowledge... 37
Table of Contents Preface..... 17 About the Authors... 19 How This Book is Organized... 20 Who Should Buy This Book?... 20 Where to Find Answers to Review Questions and Exercises... 20 How to Report Errata...
More informationMethodology for Non-Randomized Clinical Trials: Propensity Score Analysis Dan Conroy, Ph.D., inventiv Health, Burlington, MA
PharmaSUG 2014 - Paper SP08 Methodology for Non-Randomized Clinical Trials: Propensity Score Analysis Dan Conroy, Ph.D., inventiv Health, Burlington, MA ABSTRACT Randomized clinical trials serve as the
More informationCardiac Dysrhythmias and Sports
Sudden unexpected death during athletic participation is the overriding consideration in advising individuals with dysrhythmias about participation in sports. The incidence of sudden death is 1 to 2 per
More informationCardiac Examination. Pediatrics Clinical Examination
Pediatrics Clinical Examination Symptoms of Cardiovascular Affection: Cardiac Examination 1. Perinatal history: Maternal DM, cyanosis, respiratory distress 2. Symptoms of lung congestion: Poor interrupted
More informationFull Novartis CTRD Results Template
Full Novartis CTRD Results Template Sponsor Novartis Generic Drug Name vildagliptin Therapeutic Area of Trial Type 2 diabetes Approved Indication Type 2 diabetes Protocol Number CLAF237A23137E1 Title A
More informationCase # 1. Page: 8. DUKE: Adams
Case # 1 Page: 8 1. The cardiac output in this patient is reduced because of: O a) tamponade physiology O b) restrictive physiology O c) coronary artery disease O d) left bundle branch block Page: 8 1.
More informationClassification of Neoplasms
Classification of Neoplasms ICD-10 Chapter 2, Neoplasms Codes C00-D48 Notes at beginning of Chapter 2 Classified by behaviour and site Correct use of Alphabetic index required Main terms Modifiers Table
More informationClinicalTrials.gov Protocol Registration and Results System (PRS) Receipt Release Date: 01/19/2016. ClinicalTrials.gov ID: NCT
ClinicalTrials.gov Protocol Registration and Results System (PRS) Receipt Release Date: 01/19/2016 ClinicalTrials.gov ID: NCT00595413 Study Identification Unique Protocol ID: 27905 Brief Title: Atacicept
More informationImputing Dose Levels for Adverse Events
Paper HO03 Imputing Dose Levels for Adverse Events John R Gerlach & Igor Kolodezh CSG Inc., Raleigh, NC USA ABSTRACT Besides the standard reporting of adverse events in clinical trials, there is a growing
More informationcurrent, and acting like
Heart 10 IV. HEART PHYSIOLOGY - How the heart beats. How the heart depolarizes the myocardium, which leads to a contraction. A) INTRINSIC CONTROL - Heart controls its own rhythm. HOW? The presence of gap
More informationClinicalTrials.gov Protocol Registration and Results System (PRS) Receipt Release Date: 10/11/2013. ClinicalTrials.gov ID: NCT
ClinicalTrials.gov Protocol Registration and Results System (PRS) Receipt Release Date: 10/11/2013 ClinicalTrials.gov ID: NCT00168454 Study Identification Unique Protocol ID: 191622-077 Brief Title: A
More informationCMS Limitations Guide - Radiology Services
CMS Limitations Guide - Radiology Services Starting October 1, 2015, CMS will update their existing medical necessity limitations on tests and procedures to correspond to ICD-10 codes. This limitations
More informationThe study listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not
The study listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not reflect the overall results obtained on studies of a product.
More informationBio 104 Cardiovascular System
29 Blood: Introduction (Chapter 14) A. Characteristics of Blood 1. Blood Volume Lecture Outline: Cardiovascular System Hole s HAP [Chapters 14, 15, 16] 2. Blood Composition a. Blood Cells Red blood cells
More informationGenerate Informative Clinical Laboratory Results Listing
PharmaSUG2011 - Paper PO02 Generate Informative Clinical Laboratory Results Listing Sai Ma, Everest Clinical Research Services Inc., Markham, Ontario Canada ABSTRACT Clinical laboratory results review
More informationStudy No.: Title: Phase: Study Period: Study Design: Centres: Indication: Treatment: Objectives: Primary Outcome/Efficacy Variable:
The study listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not reflect the overall results obtained on studies of a product.
More informationCardiology Competency Based Goals and Objectives
Cardiology Competency Based Goals and Objectives COMPETENCY 1. Patient Care. Provide family centered patient care that is developmentally and age appropriate, compassionate, and effective for the treatment
More informationA SAS Macro to Investigate Statistical Power in Meta-analysis Jin Liu, Fan Pan University of South Carolina Columbia
Paper 109 A SAS Macro to Investigate Statistical Power in Meta-analysis Jin Liu, Fan Pan University of South Carolina Columbia ABSTRACT Meta-analysis is a quantitative review method, which synthesizes
More informationData Analysis and Query Building with MedDRA
Data Analysis and Query Building with MedDRA MedDRA was developed under the auspices of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH). The
More informationIB TOPIC 6.2 THE BLOOD SYSTEM
IB TOPIC 6.2 THE BLOOD SYSTEM THE BLOOD SYSTEM TERMS TO KNOW circulation ventricle artery vein 6.2.U1 - Arteries convey blood at high pressure from the ventricles to the tissues of the body Circulation
More informationElectrical System Overview Electrocardiograms Action Potentials 12-Lead Positioning Values To Memorize Calculating Rates
Electrocardiograms Electrical System Overview James Lamberg 2/ 74 Action Potentials 12-Lead Positioning 3/ 74 4/ 74 Values To Memorize Inherent Rates SA: 60 to 100 AV: 40 to 60 Ventricles: 20 to 40 Normal
More informationCardiovascular System
Cardiovascular System angio BELLWORK Day One: Define using technology hemo/hema cardio Medical Therapeutics Standards 11) Outline the gross normal structure and function of all body systems and summarize
More informationUsing Direct Standardization SAS Macro for a Valid Comparison in Observational Studies
T07-2008 Using Direct Standardization SAS Macro for a Valid Comparison in Observational Studies Daojun Mo 1, Xia Li 2 and Alan Zimmermann 1 1 Eli Lilly and Company, Indianapolis, IN 2 inventiv Clinical
More informationCardiac Telemetry Self Study: Part One Cardiovascular Review 2017 THINGS TO REMEMBER
Please review the above anatomy of the heart. THINGS TO REMEMBER There are 3 electrolytes that affect cardiac function o Sodium, Potassium, and Calcium When any of these electrolytes are out of the normal
More informationCongenital heart disease. By Dr Saima Ali Professor of pediatrics
Congenital heart disease By Dr Saima Ali Professor of pediatrics What is the most striking clinical finding in this child? Learning objectives By the end of this lecture, final year student should be able
More informationLab 8: Multiple Linear Regression
Lab 8: Multiple Linear Regression 1 Grading the Professor Many college courses conclude by giving students the opportunity to evaluate the course and the instructor anonymously. However, the use of these
More informationCombining Electronic Diary Seizure Data with Visit-Based Seizure Data in the MONEAD Study
PharmaSUG 2018 - Paper RW-02 Combining Electronic Diary Seizure Data with Visit-Based Seizure Data in the MONEAD Study Julia Skinner and Ryan May, Emmes Corporation ABSTRACT Electronic diary (ediary) mobile
More informationADaM Tips for Exposure Summary
ABSTRACT PharmaSUG China 2016 Paper 84 ADaM Tips for Exposure Summary Kriss Harris, SAS Specialists Limited, Hertfordshire, United Kingdom Have you ever created the Analysis Dataset for the Exposure Summary
More informationPATIENT WITH ARRHYTHMIA IN DENTIST S OFFICE. Małgorzata Kurpesa, MD., PhD. Chair&Department of Cardiology
PATIENT WITH ARRHYTHMIA IN DENTIST S OFFICE Małgorzata Kurpesa, MD., PhD. Chair&Department of Cardiology Medical University of Łódź The heart is made up of four chambers Left Atrium Right Atrium Left Ventricle
More informationIntro to SPSS. Using SPSS through WebFAS
Intro to SPSS Using SPSS through WebFAS http://www.yorku.ca/computing/students/labs/webfas/ Try it early (make sure it works from your computer) If you need help contact UIT Client Services Voice: 416-736-5800
More informationFigure ) The specific chamber of the heart that is indicated by letter A is called the. Diff: 1 Page Ref: 364
Essentials of Anatomy and Physiology, 9e (Marieb) Chapter 11 The Cardiovascular System Short Answer Figure 11.1 Using Figure 11.1, identify the following: 1) The Purkinje fibers are indicated by label.
More informationComorbidity or medical history Existing diagnoses between 1 January 2007 and 31 December 2011 AF management care AF symptoms Tachycardia
Supplementary Table S1 International Classification of Disease 10 (ICD-10) codes Comorbidity or medical history Existing diagnoses between 1 January 2007 and 31 December 2011 AF management care I48 AF
More informationCMS Limitations Guide - Cardiovascular Services
CMS Limitations Guide - Cardiovascular Services Starting October 1, 2015, CMS will update their existing medical necessity limitations on tests and procedures to correspond to ICD-10 codes. This limitations
More informationKnowledge is Power: The Basics of SAS Proc Power
ABSTRACT Knowledge is Power: The Basics of SAS Proc Power Elaina Gates, California Polytechnic State University, San Luis Obispo There are many statistics applications where it is important to understand
More informationCollapsing Longitudinal Data Across Related Events and Imputing Endpoints
Collapsing Longitudinal Data Across Related Events and Imputing Endpoints James Joseph, INC Research, King of Prussia, PA INTRODUCTION When attempting to answer a research question, the best study design
More informationThe Cardiovascular System
C H A P T E R 1 4 The Cardiovascular System OBJECTIVES After studying this chapter, you should be able to: 1. Describe how the heart is positioned in the thoracic cavity. 2. List and describe the layers
More informationThe Cardiovascular System
PowerPoint Lecture Slide Presentation by Patty Bostwick-Taylor, Florence-Darlington Technical College The Cardiovascular System 11 PART A The Cardiovascular System A closed system of the heart and blood
More information4. The two inferior chambers of the heart are known as the atria. the superior and inferior vena cava, which empty into the left atrium.
Answer each statement true or false. If the statement is false, change the underlined word to make it true. 1. The heart is located approximately between the second and fifth ribs and posterior to the
More informationDiseases of the Conduction System
4 CHAPTER 4 Diseases of the Conduction System Diseases of the conduction system are numerous and varied. The authors have selected a few representative entities for this section: complete heart block as
More informationGloucester City Council
Gloucester City Council Medical Examination Report To be filled in by the Doctor. The Patient must fill in sections 9 and 10 in the doctor s presence (please use black ink) Before filling in this form,
More informationPediatrics. Arrhythmias in Children: Bradycardia and Tachycardia Diagnosis and Treatment. Overview
Pediatrics Arrhythmias in Children: Bradycardia and Tachycardia Diagnosis and Treatment See online here The most common form of cardiac arrhythmia in children is sinus tachycardia which can be caused by
More informationBME 5742 Bio-Systems Modeling and Control. Lecture 41 Heart & Blood Circulation Heart Function Basics
BME 5742 Bio-Systems Modeling and Control Lecture 41 Heart & Blood Circulation Heart Function Basics Dr. Zvi Roth (FAU) 1 Pumps A pump is a device that accepts fluid at a low pressure P 1 and outputs the
More informationThe production of murmurs is due to 3 main factors:
Heart murmurs The production of murmurs is due to 3 main factors: high blood flow rate through normal or abnormal orifices forward flow through a narrowed or irregular orifice into a dilated vessel or
More informationSponsor. Generic Drug Name. Trial Indications. Protocol Number. Protocol Title. Clinical Trial Phase. Study Start/End Dates. Reason for Termination
Sponsor Alcon Research, Ltd. Generic Drug Name Travoprost/timolol maleate Trial Indications Open-angle glaucoma or ocular hypertension Protocol Number C-09-007 Protocol Title An Evaluation of Patient Reported
More information4Stat Wk 10: Regression
4Stat 342 - Wk 10: Regression Loading data with datalines Regression (Proc glm) - with interactions - with polynomial terms - with categorical variables (Proc glmselect) - with model selection (this is
More informationThe production of murmurs is due to 3 main factors:
Heart murmurs The production of murmurs is due to 3 main factors: high blood flow rate through normal or abnormal orifices forward flow through a narrowed or irregular orifice into a dilated vessel or
More informationGraph Display of Patient Profile Using SAS
PharmaSUG 2018 - Paper DV-17 Graph Display of Patient Profile Using SAS Yanwei Han, Seqirus USA Inc., Cambridge, MA Hongyu Liu, Seqirus USA Inc., Cambridge, MA ABSTRACT We usually create patient profile
More information(2) (1) (3) (4) BLOOD PATHWAY ASSESSMENT RUBRIC
BLOODPATHWAYASSESSMENT(4) BLOOD%PATHWAY%ASSESSMENT%(3)% BLOODPATHWAYASSESSMENT(3) (4) (3) (2) (1) Using a completely blank diagram of the heart, all valves, chambers, great vessels, and direction of blood
More informationAE: An Essential Part of Safety Summary Table Creation. Rucha Landge, Inventiv International Pharma Services Pvt. Ltd.
PharmaSUG 2016 - Paper IB11 AE: An Essential Part of Safety Summary Table Creation. Rucha Landge, Inventiv International Pharma Services Pvt. Ltd., Pune, India ABSTRACT Adverse event (AE) summary tables
More informationThe Cardiovascular System
Essentials of Human Anatomy & Physiology Elaine N. Marieb Slides 11.1 11.19 Seventh Edition Chapter 11 The Cardiovascular System Functions of the Cardiovascular system Function of the heart: to pump blood
More informationHome Health Prospective Payment System. Overview
Overview Version 6117 January 2017 PBL-046 Java is a registered trademark of Oracle and/or its affiliates. Table of Contents Overview of the... 5 Background and versioning... 5 Changes for this version...
More informationJUSTUS WARREN TASK FORCE MEETING DECEMBER 05, 2012
SAMUEL TCHWENKO, MD, MPH Epidemiologist, Heart Disease & Stroke Prevention Branch Chronic Disease & Injury Section; Division of Public Health NC Department of Health & Human Services JUSTUS WARREN TASK
More informationCardiac Implanted Electronic Devices Pacemakers, Defibrillators, Cardiac Resynchronization Devices, Loop Recorders, etc.
Cardiac Implanted Electronic Devices Pacemakers, Defibrillators, Cardiac Resynchronization Devices, Loop Recorders, etc. The Miracle of Living February 21, 2018 Matthew Ostrom MD,FACC,FHRS Division of
More informationCARDIOVASCULAR DISEASE Maintenance of Certification (MOC) Examination Blueprint
CARDIOVASCULAR DISEASE Maintenance of Certification (MOC) Examination Blueprint ABIM invites diplomates to help develop the Cardiovascular Disease MOC exam blueprint Based on feedback from physicians that
More informationADVANCED VBA FOR PROJECT FINANCE Near Future Ltd. Registration no
ADVANCED VBA FOR PROJECT FINANCE f i n a n c i a l f o r e c a s t i n G 2017 Near Future Ltd. Registration no. 10321258 www.nearfuturefinance.com info@nearfuturefinance.com COURSE OVERVIEW This course
More informationENROLLMENT : Line of Business Summary
ENROLLMENT : Line of Business Summary Date Range : JAN 2017 through DEC 2017 COMPREHENSIVE MAJOR MEDICAL Print Date : 1/19/2018 9:43:49AM Page 1 of 1 Month Year Single 2 Person : Emp/Spouse 2 Person :
More informationA Comparison of Linear Mixed Models to Generalized Linear Mixed Models: A Look at the Benefits of Physical Rehabilitation in Cardiopulmonary Patients
Paper PH400 A Comparison of Linear Mixed Models to Generalized Linear Mixed Models: A Look at the Benefits of Physical Rehabilitation in Cardiopulmonary Patients Jennifer Ferrell, University of Louisville,
More informationNDoc Reference for the July 2012 Patient Demographic Enhancements
Summary: This document provides a summary of the patient demographic enhancements incorporated in the July 2012 Update, including changes to the entry of patient names, the charting of patient address
More informationACLS Study Guide for Precourse Self-Assessment
20 rhythm strips on Precourse Self-Assessment with the following matching choices: Agonal Rhythm/Asystole Atrial Fibrillation Flutter Ventricular Fibrillation Monomorphic Ventricular Normal Sinus Rhythm
More informationGraduate Certificate in Electrocardiograph (ECG) Interpretation. Code 10447NAT
Graduate Certificate in Electrocardiograph (ECG) Code 10447NAT On behalf of The Benchmarque Group, I am delighted to introduce you to our Graduate Certificate in Electrocardiograph (ECG). This self directed
More informationPrinciples of Biomedical Systems & Devices. Lecture 8: Cardiovascular Dynamics Dr. Maria Tahamont
Principles of Biomedical Systems & Devices Lecture 8: Cardiovascular Dynamics Dr. Maria Tahamont Review of Cardiac Anatomy Four chambers Two atria-receive blood from the vena cave and pulmonary veins Two
More informationAnatomy lab -1- Imp note: papillary muscle Trabeculae Carneae chordae tendineae
Anatomy lab -1- Imp note: the arrangement of this sheet is different than the lab recording, it has been arranged in a certain way to make it easier to study. When you open the left ventricle you can see
More information2.1 Numerator: The number of denominator continuous inpatient spells (i.e. spells excluding those with a diagnosis
2) Hospital case-fatality 2.1 Numerator: The number of denominator continuous inpatient spells (i.e. spells excluding those with a diagnosis of cancer anywhere in the spell) where the patient dies in hospital
More information: Provide cardiovascular preventive counseling to parents and patients with specific cardiac diseases about:
Children s Hospital & Research Center Oakland Cardiology Primary Goals for this Rotation 5.13 GOAL: Prevention, Counseling and Screening (Cardiovascular). Understand the role of the pediatrician in preventing
More information